SMARCA4 and cancer: Depletion of SMARCA2 in SMARCA4-deficient melanoma cells abrogates melanoma tumorigenicity [77] and systematic studies in other cancers have shown that loss of one subunit renders cells highly dependent on the paralogous subunit [98].